Abstract:Rhabdomyosarcoma, which accounts for 20% of all malignant tumors of the heart, is an aggressive tumor originating in the ventricular wall. These tumors are the second most common malignant primary tumor of the heart after angiosarcoma. Despite treatment options, such as surgical resection, radiotherapy, and chemotherapy, recurrence is common and mortality is high. Among these patients, survival with surgical resection is around six months to one year. In this case report, we discuss a patient who presented wit… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.